Literature DB >> 3280486

Oral contraceptives and hypertension.

J W Woods1.   

Abstract

Oral contraceptives result in a mild elevation of blood pressure in most women and overt hypertension in about 5%. Both estrogen and progestogen are responsible for the blood pressure effect, but the mechanism is as yet unknown. The risk of cardiovascular complications is found primarily in women over 35 years of age and in those who smoke. Preparations with an estrogen content of 30 g and a progestogen content of 1 mg or less appear to be safe.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280486     DOI: 10.1161/01.hyp.11.3_pt_2.ii11

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  17 in total

1.  The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate.

Authors:  Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

2.  Infertility, fertility treatment, and risk of hypertension.

Authors:  Leslie V Farland; Francine Grodstein; Serene S Srouji; John P Forman; Janet Rich-Edwards; Jorge E Chavarro; Stacey A Missmer
Journal:  Fertil Steril       Date:  2015-06-11       Impact factor: 7.329

Review 3.  Sex-Specific Disparities in Risk Factors for Coronary Heart Disease.

Authors:  Stacey E Rosen; Sonia Henry; Rachel Bond; Camille Pearte; Jennifer H Mieres
Journal:  Curr Atheroscler Rep       Date:  2015-08       Impact factor: 5.113

4.  Chronic estrogen exposure affects gene expression in the rostral ventrolateral medulla of young and aging rats: Possible role in hypertension.

Authors:  Madhan Subramanian; Coral Hahn-Townsend; Kimberly A Clark; Sheba M J MohanKumar; P S MohanKumar
Journal:  Brain Res       Date:  2015-09-12       Impact factor: 3.252

5.  Chronic estradiol-17β exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol.

Authors:  Madhan Subramanian; Priya Balasubramanian; Hannah Garver; Carrie Northcott; Huawei Zhao; Joseph R Haywood; Gregory D Fink; Sheba M J MohanKumar; P S MohanKumar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-03-16       Impact factor: 3.619

Review 6.  Estrogen and hypertension.

Authors:  Muhammad S Ashraf; Wanpen Vongpatanasin
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

7.  Hypertension in women.

Authors:  Sandra J Taler
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

8.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 9.  Resistant Hypertension Updated Guidelines.

Authors:  Irene Chernova; Namrata Krishnan
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

Review 10.  Drug-induced cardiovascular disorders.

Authors:  C Aengus Murphy; Henry J Dargie
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.